These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31880233)

  • 21. Comparability of blinded remote and site-based assessments of response to adjunctive esketamine or placebo nasal spray in patients with treatment resistant depression.
    Targum SD; Daly E; Fedgchin M; Cooper K; Singh JB
    J Psychiatr Res; 2019 Apr; 111():68-73. PubMed ID: 30685564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
    Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
    JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Syndrome Rather Than Body Mass Index Is Associated With Treatment Response to Ketamine Infusions.
    Dale RM; Bryant KA; Thompson NR
    J Clin Psychopharmacol; 2020; 40(1):75-79. PubMed ID: 31834094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series.
    Wallner MA; Eloge JC; Mackey IV; Zajecka J
    J Clin Psychiatry; 2023 Feb; 84(2):. PubMed ID: 36724112
    [No Abstract]   [Full Text] [Related]  

  • 25. Ketamine helps a third of patients with treatment resistant depression, finds small UK study.
    Torjesen I
    BMJ; 2014 Apr; 348():g2576. PubMed ID: 24699320
    [No Abstract]   [Full Text] [Related]  

  • 26. Three Months of Treatment With Esketamine: Effects on Depression, Insomnia, and Weight.
    Stultz DJ; Stanley N; Gills T; Osburn S; Burns T; Moomaw S; Pawlowska-Wajswol S; Walton R
    Prim Care Companion CNS Disord; 2020 Jul; 22(4):. PubMed ID: 32649066
    [No Abstract]   [Full Text] [Related]  

  • 27. Ketamine for Depression, 3: Does Chirality Matter?
    Andrade C
    J Clin Psychiatry; 2017 Jun; 78(6):e674-e677. PubMed ID: 28682536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esketamine for treatment-resistant depression.
    Drug Ther Bull; 2020 Dec; 58(12):183-188. PubMed ID: 33243929
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis.
    Papakostas GI; Salloum NC; Hock RS; Jha MK; Murrough JW; Mathew SJ; Iosifescu DV; Fava M
    J Clin Psychiatry; 2020 May; 81(4):. PubMed ID: 32459407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can we confidently use ketamine as a clinical treatment for depression?
    Loo C
    Lancet Psychiatry; 2018 Jan; 5(1):11-12. PubMed ID: 29277196
    [No Abstract]   [Full Text] [Related]  

  • 31. Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
    Nijs M; Wajs E; Aluisio L; Turkoz I; Daly E; Janik A; Borentain S; Singh JB; DiBernardo A; Wiegand F
    Int J Neuropsychopharmacol; 2020 Jul; 23(7):426-433. PubMed ID: 32270176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium.
    Vázquez GH; Bahji A; Undurraga J; Tondo L; Baldessarini RJ
    J Psychopharmacol; 2021 Aug; 35(8):890-900. PubMed ID: 34238049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S-(+)-ketamine-induced dissociative symptoms as a traumatic experience in patients with treatment-resistant depression.
    Correia-Melo FS; Silva SS; Araújo-de-Freitas L; Quarantini LC
    Braz J Psychiatry; 2017; 39(2):188-189. PubMed ID: 28591272
    [No Abstract]   [Full Text] [Related]  

  • 34. Intravenous ketamine for treatment-resistant major depressive disorder.
    Covvey JR; Crawford AN; Lowe DK
    Ann Pharmacother; 2012 Jan; 46(1):117-23. PubMed ID: 22190250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Ketamine as antidepressant: the current study situation].
    Ritter PS; Bauer M; Pilhatsch M
    Nervenarzt; 2014 Nov; 85(11):1432-5. PubMed ID: 25324145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effectiveness between Ketamine and Esketamine: the predictive role of dissociative features. A treatment-resistant depression case.
    Ragone N; Barbini B; Passani C; Seghi F; Colombo C
    Int Clin Psychopharmacol; 2024 Mar; 39(2):117-119. PubMed ID: 37551582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
    Surjan J; Grossi JD; Del Porto JA; Delfino RS; de Oliveira Cerqueira R; Lucchese AC; Magalhães E; Del Sant LC; Tuena MA; Nakahira C; Fava VAR; Steglich MS; Abdo GL; Barbosa MG; Sarin LM; Lacerda ALT
    Clin Drug Investig; 2022 Oct; 42(10):865-873. PubMed ID: 36044154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketamine for the treatment of depression.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2013 Jan; 51(1):11-4. PubMed ID: 23413455
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Key considerations for the use of ketamine and esketamine for the treatment of depression: focusing on administration, safety, and tolerability.
    Kritzer MD; Pae CU; Masand PS
    Expert Opin Drug Saf; 2022 Jun; 21(6):725-732. PubMed ID: 35475388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine.
    Chang L; Zhang K; Pu Y; Qu Y; Wang SM; Xiong Z; Ren Q; Dong C; Fujita Y; Hashimoto K
    Pharmacol Biochem Behav; 2019 Jun; 181():53-59. PubMed ID: 31034852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.